See also this year's filing and all EDGAR filings for this company.
PDF Report 0000906709_2022_NEKTAR_THERAPEUTICS.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000906709, NEKTAR THERAPEUTICS
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 795,581,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 76,501,000 |
| 2 | PropertyPlantAndEquipmentNet | 60,510,000 |
| 3 | remainder_Assets | 184,597,000 |
| 4 | LiabilitiesCurrent | 85,200,000 |
| 5 | LiabilitiesNoncurrent | 129,328,000 |
| 6 | remainder_Liabilities | 223,153,000 |
| 7 | CostOfGoodsAndServicesSold | 24,897,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 122,844,000 |
| 9 | ResearchAndDevelopmentExpense | 400,269,000 |
| 10 | remainder_Expenses | 557,000 |
| 11 | remainder_Revenues | 101,907,000 |
| 12 | remainder_NetIncome | -77,177,000 |
| 13 | remainder_ComprehensiveNetIncome | -1,862,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,117,189,000 |
| 1 | Liabilities | 437,681,000 |
| 2 | Expenses | 548,567,000 |
| 3 | Revenues | 101,907,000 |
| 4 | StockholdersEquity | 679,508,000 |
| 5 | NetIncome | -523,837,000 |
| 6 | ComprehensiveNetIncome | -524,768,000 |
| 7 | BaseVar | 1,142,191,500 |
| 8 | EconomicCapitalRatio | 0.828 |
Edgar->Model Mapping
Feature Distribution
Change over Time
